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Trends in Sample Preparation for 
Proteome Analysis
Jakub Faktor, David R. Goodlett and Irena Dapic
Abstract
Sample preparation is a key step in proteomics, however there is no consensus in 
the community about the standard method for preparation of proteins from clinical 
samples like tissues or biofluids. In this chapter, we will discuss some important 
steps in sample preparation used for bottom-up proteome profiling with mass 
spectrometry (MS). Specifically, tissues, which are an important source of biologi-
cal information, are of interest because of their availability. Tissues are most often 
stored as fresh frozen (FF) or formalin-fixed paraffin-embedded (FFPE). While 
FF tissues are more readily available, paraffin embedding has historically been 
routinely used for tissue preservation. However, formaldehyde induced crosslinks 
during FFPE tissue preservation present a challenge to the protocols used for 
protein retrieval. Moreover, in our view, an important aspect to consider is also the 
amount of material available at the start of a protocol since this is directly related 
to the choice of protocol in order to minimize sample loss and maximize detection 
of peptides by MS. This “MS sensitivity” is of special importance when working 
with patient samples that are unique and often available in limited amounts making 
optimization of methods to analyze the proteins therein important given that their 
molecular information can be used in a patients’ diagnosis and treatment.
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1. Introduction
Proteomics is an important tool in the study of human biological material with 
the aim to extract knowledge that can improve a patients’ treatment outcomes. 
Molecular information obtained from patient samples can be complementary to 
pathological observations all with the goal of faster and more accurate diagnosis, 
and subsequent treatment. Molecular analysis of tissue by proteomics can lead to 
disease classification and reveal underlying disease pathways that can further serve 
as a target for medical treatment.
Sample size and origin is an important aspect in sample preparation. Today, there 
are numerous sample preparation procedures existing which aim to improve sensitiv-
ity of detection or protein recovery from a sample. Release of proteins from native 
or artificial material is a crucial step in sample preparation and to improve protein 
recovery there are different additives such as detergents, chaotropes, buffers and 
salts added during the sample preparation that must be considered. Moreover, target-
ing special groups of proteins (e.g. membrane proteins), which are involved in key 
cellular functions and may be a target of pharmaceutical treatment, often represent a 
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challenge in their isolation and analysis. Their amphipathic nature may require use of 
appropriate enrichment procedures all with the goal to achieve better detection.
Further, sample loss during most standard preparation procedures is inevi-
table, and it is even more accentuated when minute amounts of material are being 
processed. To minimize sample loss and thus increase sensitivity of the analysis at 
the MS step there have recently been several technologies developed. Specifically, 
improvement in technologies that allow detection of proteins down to a single cell 
have become available. Some of these technologies, such as nanoPOTS and micro-
POTS, have already been applied to human tissues. These new possibilities to anal-
yse small regions of tissue samples with sufficient sensitivity is opening the door 
to many applications such as profiling of selected regions of a tumorous zone or 
detection of proteins from subcellular populations. These new applications aimed 
at working with 1 to 100s or 1000s of cells will likely have increasing importance in 
clinics, but only if they can be developed into routine and robust methods.
2. Tissue preservation
Human tissue samples are a valuable source of information for diagnostics, 
therefore a lot of effort has gone into best preservation methods that minimize 
changes that can occur over time in storage. For example, following clinical surgery 
tissues need to be stored according to the protocols that minimize chemical, enzy-
matic, mechanical or thermal degradation and protect their molecular content. 
Today, tissues are most often preserved as fresh frozen (FF) or formalin-fixed 
paraffin-embedded (FFPE) tissues.
2.1 Fresh frozen tissues
FF tissues are obtained usually with snap freezing of tissues where the temperature 
achieved is below −70°C, most often in dry ice or liquid nitrogen (Figure 1B). To 
minimize variability between the samples storage and thus to minimize potential 
effect on molecular structure and integrity of the tissue, the European Human Frozen 
Tumour tissue bank (TuBa-Frost) has standardized tissue preservation by freezing 
in 2006 [1, 2]. An important aspect in preservation of tissues by the FF method is 
prevention of formation of artefacts that might result in changes to the tissue structure 
and morphology. For example, ice crystals that can disrupt structures within the tissue 
may form as a consequence of the freezing procedure due to moisture present within 
the tissue [3]. An alternative to snap freezing is the optimal cutting temperature 
(OCT) compound, which is used for tissue embedding and contains polyvinyl alcohol, 
polyethylene glycol (PEG) and benzalonium chloride. The OCT substance preserves 
tissue and enables optimal microdissection of the tissue. However, where samples will 
later be analyzed by mass spectrometry (MS), OCT compounds must be removed 
prior to analysis. This is usually achieved by washing the tissue with a special grade of 
alcohol or Carnoy’s fluid [4] or with the use of other protocols for sample purification.
2.2 Formalin-fixed paraffin-embedded tissues
An alternative to preservation of tissue by the FF process is the use of FFPE 
methods (Figure 1A), which are routinely used by pathologists around the globe 
to preserve tissue by embedding in paraffin. The FFPE process preserves tissues by 
chemical fixation most often in 10% of formalin and is followed later by embed-
ding in paraffin to form a tissue block for subsequent slicing. The combination of 
formalin fixation with paraffin embedding allows for long term storage of tissues. 
3
Trends in Sample Preparation for Proteome Analysis
DOI: http://dx.doi.org/10.5772/intechopen.95962
Also, FFPE tissues are often used for histopathological studies, a routine process in 
examination of a patient’s biopsies and clinical material [5]. Moreover, it is known 
that formalin leads to chemical modification of proteins in the fixed tissues caus-
ing cross-linking between proteins and modifications most often as methylation 
(+14 Da) as well as formation of methylene and methylol adducts to a lesser extent. 
As a consequence of formaldehyde induced modifications, the molecular weight or 
physicochemical properties of fixed proteins can be altered.
3. Preparation of the sample for bottom-up proteomics
Protein extraction and the subsequent preparation for LC–MS analysis represents 
one of the key steps in proteomics (Figure 2). While there have been numerous 
protocols reported, they have mainly focused on preparation from large amounts 
(i.e. micrograms to milligrams) of material, which limits their utility in the study of 
patient clinical samples. Notably, protein extraction from FFPE preserved tissues 
requires removal of formaldehyde-formed cross links, which is usually carried 
out by heating samples in a buffered solution at an elevated temperature (95°C or 
100°C). The most common buffers used for protein extraction are ammonium bicar-
bonate, tris(hydroxymethyl)aminomethane (Tris), and Radioimmunoprecipitation 
assay (RIPA) buffer. Addition of detergents to the buffer composition (e.g. sodium 
dodecyl sulfate (SDS), sodium dodecyl cholate (SDC), RapiGest SF surfactant™ 
(Waters), PPS Silent Surfactant™ (Expedeon) have been routinely used to improve 
protein solubilization efficiency and thus enhance protein extraction. In addition 
to optimization of the extraction buffers many studies also optimized other param-
eters like incubation time of the extraction and/or addition of various proteases to 
improve protein coverage during subsequent LC–MS/MS analysis.
Figure 1. 
Overview of tissue sample processing prior to proteomic experiments. A) Tissues can be preserved and stored for 
long periods of time by formalin fixation and paraffin embedding which has been routinely used for decades. 
Proteomic analysis of FFPE tissues can be accompanied with laser capture microdissection (LCM) which helps 
to retrieve regions of interest on tissue sections. Further steps involve isolation of the proteins from the sections in 
appropriate lysis buffers and further processing for protein analysis by MS. B) Tissues can be preserved by freezing 
and further stored at low temperatures. Tissue should be frozen as soon as possible after retrieval and tissue can 
be sectioned prior to proteomic sample preparation. Tissue sections are further prepared for protein isolation, but 
also single cell isolation protocols could be employed to retrieve limited cell subsets prior protein extraction.
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3.1 Detergents
Traditional detergents and chaotropes such as SDS and urea have been widely 
used for protein solubilization, however they are also well known to inhibit diges-
tion at higher concentrations and are incompatible with reversed phase chroma-
tography separation (RPLC) used to introduce samples for MS analysis. Therefore, 
their concentration must be kept low at the time of proteolysis in order to preserve 
the effectiveness of proteases used for protein digestion. Failure to do so often 
leads to incomplete protein solubilization and denaturation. Also, presence of 
detergents in the sample might interfere with later instrumental analysis, therefore 
there have been different purification methods developed for detergent removal 
to improve LC–MS outcome. The choice of the most effective procedure depends 
on the physicochemical properties of the detergent. Some of the procedures might 
include detergent removal on the basis of size exclusion (i.e. molecular weight 
cut-off filters) or with the use of spin columns containing appropriate resins for 
detergent removal. Moreover, heating of the sample in urea buffers often leads to 
covalent modification of proteins via carbamylation, which might affect peptide 
retention time during RPLC separation and if not accounted for will interfere with 
identification. In order to circumvent these problems caused by mass spectrometry 
incompatible detergents significant effort went into development of reagents that 
avoid these complications. To this end, acid labile detergents such as RapiGest SF 
surfactant™ (Waters) and PPS Silent Surfactant™ (Expedeon) were developed that 
could be easily removed after proteolysis by simple measures like decreasing the 
pH. For example, the MS compatible surfactant ProteaseMAX™ (Promega) surfac-
tant enhances tryptic, chymotryptic and LysC digestion and then degrades during 
the course of a digestion reaction. Another compound, Invitrosol™ (Thermo Fisher 
Scientific) is a homogenous surfactant that does not impact tryptic digestion and 
elutes during RPLC in three peaks well separated from where peptides elute [6].
3.2 Sample digestion
Classical bottom-up proteomic sample preparation aims to turn protein extracts 
into peptides via a process of protein cleavage or digestion with proteases. Notably, 
proteins extracted from biological material tend to keep their native tertiary 
 structure mostly held by non-covalent interactions of amino acid side groups [7].  
Figure 2. 
Overview of sample preparation for bottom-up proteomic analysis by tandem mass spectrometry. A) Sample 
lysis: proteins are extracted from biological matrix in lysis buffer. Mechanical disintegration or sonification 
is used to homogenize rigid structures present within samples such as is common in mammalian tissue. B) 
Protein digestion: proteins are proteolytically digested into peptides, usually by the protease trypsin. C) Peptide 
fractionation: optionally, the complexity of the peptide sample is decreased by addition of fractionation steps 
orthogonal to methods used in the next step. D) Mass spectrometry analysis: desalted peptide samples are 
dissolved in an appropriate buffer and introduced into a tandem mass spectrometer. Most often reversed phase 
liquid chromatography separation is used in this final step to enable sequential introduction of peptides into the 
tandem mass spectrometer.
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It is thus essential to disrupt the tertiary structure and linearize the protein 
sequence to ease the accessibility of proteases to cleavage sites. Protein tertiary 
structure is frequently disrupted by chaotropic and denaturing reagents. Disulfide 
bonding contributes to tertiary structure as well via a covalent bond between 
cysteine side chain groups also termed an S-S bridge. Disulphide bonds are most 
often broken by use of reducing agents leaving free sulfhydryl groups available that 
allow the protein to unfold more fully. Dithiothreitol (DTT), tris (2-carboxyethyl) 
phosphine (TCEP), tris (3-hydroxypropyl) phosphine (THPP) and 2-mercapto-
ethanol (2-ME) are the most commonly used reducing agents. Sulphur containing 
reagents such as 2-ME and DTT break the S-S bridge by thiol-disulfide exchange, 
while phosphorus containing reagents form a phosphine oxide as a result of disul-
phide bond reduction [8]. Reduction is commonly followed by free sulfhydryl 
group alkylation to prevent disulphide bond reformation. In this chemistry a free 
sulfhydryl group performs a nucleophilic attack on the alpha carbon of an alkylat-
ing reagent creating a covalent bond between the alkyl group and cysteine. There 
is a wide palette of alkylating reagents that may be used, but in proteomic sample 
preparation the most commonly used reagents include iodoacetamide, iodoacetic 
acid, N-ethylmaleimide (NEM) and S-methyl methanethiosulfonate. Covalent 
modification of a free sulfhydryl group leaves a mass tag on each cysteine that must 
be considered as a mass shift to cysteine during interpretation of peptide tandem 
mass spectra. Alkylated proteins are then further processed by proteolytic cleavage, 
to shorter segments; peptides, which are then easily detected in a bottom-up experi-
ment carried out by LC–MS/MS analysis. As mentioned above peptides may be pro-
duced by enzymatic methods but also chemical methods that can be either specific 
or unspecific (Table 1). In both cases there are a variety of protocols available to 
digest proteins into peptides for mass spectrometry-based proteomic analysis.
Bottom-up proteomics frequently relies on proteolytic enzymes that digest a 
protein at specific sites. Having predictable digestion rules for a given protease 
results in a faster database search process that also makes it computationally less 
demanding and more accurate. Trypsin is the most common protease in bottom-up 
proteomics cleaving peptide bonds at the C-terminus of arginine and lysine when 
not followed by proline [16]. Notably, maintaining an optimal temperature of 37°C 
at a pH optimum between 7 and 8 in the presence of Ca2+ ions in the digestion buffer 
is important for the reaction to proceed efficiently [17]. The optimal enzyme to sub-
strate ratio is also important and for trypsin this is often from 1:20 to 1:100 (w:w). 
In some instances LysC endoproteinase, which is isolated from Lysobacter enzymo-
genes, is often combined with trypsin to provide cleavage at lysine C-terminus. This 
combination of multiple enzymes is used to enhance peptide sequence coverage by 
producing overlapping peptides. The addition of chymotrypsin and pepsin produce 
the most orthogonal peptides to trypsin. Chymotrypsin is a serine protease which 
cleaves a peptide bond at the C-terminus of large hydrophobic side chain amino 
acids such as phenylalanine, tryptophan, tyrosine and leucine. Chymotrypsin 
performs best in a 1:50 (w:w) enzyme to substrate ratio at basic pH and a tempera-
ture around 37°C. Chymotrypsin is also activated and stabilized by the presence of 
Ca2+ ions, therefore it is beneficial to use digestion buffers containing calcium ions 
(e.g. CaCl2) [18]. Pepsin is an endopeptidase that is secreted in gastric chief cells 
as an inactive precursor called pepsinogen that becomes activated by cleavage of 
an N-terminal pro-segment in acidic conditions. The optimal enzymatic activity 
of pepsin is achieved at pH 1.5–2.5 and 37°C. Pepsin cleaves at the C-terminus of 
phenylalanine, leucine and rarely after histidine and lysine, unless they are adjacent 
to leucine or phenylalanine. Pepsin is frequently used for on-column protein diges-
tion in hydrogen-deuterium exchange experiments (HDX), but also an application 

















Protease Class pH range/ion t [°C] Cleavage specificity Example application Reference
Trypsin Serine 7–8/Ca2+ 37 Arg, Lys (C-term) Primary central nervous system lymphoma [9]
LysC Serine 8.5 37 Lys (C-term) Whole liver SDS lysates [10]
LysN Metalloproteinase 7-9/Zn2+ Thermostable Lys (N-term) HEK 293 cells [11]
Chymotrypsin Serine 8/Ca2+ 37 Hydrophobic AAs (C-term) Cerebrospinal fluid (CSF) [12]
Pepsin Aspartic 1.5-2.5 37 Preferentially Phe, Leu (C-term) Human liver tissue [13]
Thermolysin Metalloproteinase 5.0–8.5 / Zn2+ 65–85 Ala, Met, Ile, Leu, Val, Phe 
(N-term)
Human liver tissue [13]
AspN Metalloproteinase 6.5–8.0 / Zn2+ 40 Asp (N-term) Brain and liver tissue from C57BL/6 mouse [14]
GluC Serine 4.0, 7.8 37 Glu, Asp (C-term) Cerebrospinal fluid (CSF), brain and liver tissue from 
C57BL/6 mouse
[12, 14]
ArgC Cysteine 7.2–8.0/Ca2+ 37 Arg, Lys (C-term) Cerebrospinal fluid (CSF), brain and liver tissue from 
C57BL/6 mouse
[12, 14]




Proteases used for proteolytic digestion of protein extracts retrieved from biological material such as tissue, body fluids or cell extract. Table 1 presents the enzyme class, pH and temperature 
optimum, inorganic ion cofactor and specificity of protease. In addition a representative application and literature source is given.
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GluC, ArgC, LysN, AspN are also popular proteases in bottom-up proteomics 
as they predictably produce complementary or orthogonal peptides to trypsin with 
different substrate affinities. GluC is a serine protease isolated from Staphylococcus 
aureus with specificity dependent on the digestion buffer composition. For example, 
performing proteolysis in phosphate buffers will lead to cleavage at the C-terminus 
of glutamic acid and asparatic acid, but only cleavage at the C-terminus of glutamic 
acid will be catalysed in ammonium acetate (pH 4.0) and ammonium bicarbonate 
(pH 7.8) buffers [20]. GluC is known to perform optimally under pH 4.0 and pH 7.8 
at 37°C while it is stable in denaturing conditions. ArgC, isolated from Clostridium 
histolyticum, is a cysteine endopeptidase cleaving at the C-terminus of arginine and 
sometimes at the C-terminus of lysine. Its pH optimum is 7.6 and Ca2+ ions also 
enhance its activity. ArgC digestion has recently been considered an alternative to 
the conventional trypsin digestion as it cleaves at the C-terminus of arginine. LysN 
is a metalloprotease that cleaves at the N-terminus of lysine and it is resistant to 
denaturation allowing digests to proceed even at temperatures higher than men-
tioned above. AspN is a selective metalloproteinase isolated from Flavobacterium 
menigosepticum requiring zinc atoms for its catalytical activity [21]. Its endopepti-
dase activity is specific to the N-terminus of aspartic acid or cysteic acid. To main-
tain optimal enzymatic activity it is recommended to include ZnSO4 in the digestion 
solution buffered between pH 6.5–8.0 at a temperature of 40°C. Combining AspN 
with trypsin digestion increases data quality and increases protein coverage [22]. 
WaLP and MaLP are less known proteases cleaving at aliphatic amino acids, which 
makes them popular for membrane proteomic applications. Meyer et al. demon-
strated that combination of data from trypsin, LysC, WaLP and MaLP digestion 
leads to an increase in membrane proteome coverage by 101%, compared to cover-
age achieved by trypsin digestion alone [23].
Broad specificity protease digestion is less common to bottom-up sample prepa-
ration, nevertheless it is used to digest rigid protein structures that resist digestion 
using common proteases. Proteinase K is one such serine endopeptidase isolated 
from fungus Engyodontium album that cleaves protein sequences with a broad 
specificity and like others discussed above requires Ca2+ ions for activity. Generally, 
it cleaves at the C-terminus of aromatic or aliphatic amino acids and is able to digest 
proteins in their native state or in presence of detergent such as SDS and Triton-X 
100, but works best at alkaline pH 7.5–12.0 and 37°C. Most frequently, it is used for 
nucleic acid purification to remove proteins, but it is also suitable for some pro-
teomic applications such as non-specific digestion of membrane proteins, protease 
footprinting or prion digestion. As the name implies thermolysin is a thermostable 
metalloproteinase isolated from Bacillus thermoproteolyticus. Thermolysin requires 
zinc and calcium ions for proteolytic activity but remains active in temperatures 
from 65–85°C and between pH 5.0 to 8.5. It cleaves at the N-terminus of alanine, 
methionine, isoleucine, leucine, valine and phenylalanine and is often used to 
digest proteins that resist proteolysis using conventional proteases [24]. Papain and 
elastase have endopeptidase activity and broad specificity that while available are 
rarely used in bottom-up sample preparation. Elastase is a serine endopeptidase that 
cleaves at the C-terminus of small hydrophobic side chains such as glycine, valine, 
isoleucine and leucine. While, papain is cysteine endopeptidase that cleaves at the 
C-terminus of arginine and lysine if it is preceded by hydrophobic amino acid, but 
not succeeded by valine. Subtilisin is a serine endopeptidase isolated from soil bac-
teria (e.g. Bacillus licheniformis) that is known to non-specifically cleave the peptide 
bond with a preference for large uncharged amino acids, although amino acids with 
basic side chains can be accepted in alternate binding mode [25]. Subtilisin remains 
active and stable under denaturing and alkaline conditions ranging from pH 8–12 
and Ca2+ ions stabilize subtilisin structure, therefore it is essential to include CaCl2 
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in a digestion buffer. Subtilisin’s use in bottom-up proteomics is quite limited due 
to its wide range of specificity, nevertheless it has been reported that it could be 
used to reveal previously hidden areas of the proteome [26]. Cathepsins form a 
large group of proteases with endopeptidase activity. Their use in proteomics is not 
frequent but nevertheless some uses have been reported. Cathepsin L is a cysteine 
protease located in lysosomes, it is physiologically involved in tissue remodeling and 
in diseases such as cancer metastasis. Cathepsin L is catalytically active at pH 3.0–
6.5 in the presence of thiol compounds [27]. Digestion using Cathepsin L has been 
reported in research of histone N-termini. Cathepsin C is a N-terminal dipeptidase 
physiologically involved in activation of serine proteases and inflammatory cells 
[28]. Its use in proteomic sample preparation is limited, as its cleavage is unspecific. 
Nevertheless, it could serve as a potent tool to generate peptides orthogonal to 
conventional proteases.
Thrombin is a serine protease which is proteolytically activated during the 
clotting process from an inactive prothrombin precursor. It is exclusively specific 
towards the Leu-Val-Pro-Arg-Gly-Ser motif. Therefore, it is most often used to 
cleave a specific linker tethered to another peptide with this sequence motif inserted 
into recombinant fusion protein constructs. There is a wide palette of these type of 
protein tag removal endopeptidases; namely Factor Xa cleaving Leu-Val-Pro-Arg-
Gly-Ser motif, Enteropeptidase cleaving Asp-Asp-Asp-Asp-Lys motif, TEV Protease 
cleaving Glu-Asn-Leu-Tyr-Phe-Gln-Gly motif, Rhinovirus 3C Protease cleaving 
Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro motif and several others [29]. Further details of 
protein tag removal proteases will not be discussed as it does not fall within scope of 
this chapter.
Finally, it should be noted that reproducible protein cleavage could be achieved 
even in non-enzymatic reactions mediated by chemical reagents. The most frequent 
chemical reagents to cleave peptide bond are dilute acids, such as hydrochloric 
acid, formic acid and acetic acid or other reagents such as cyanogen bromide 
(CNBr), hydroxylamine and 2-nitro-5-thiocyanobenzoate (NTCB) [30]. Exposure 
of proteins to dilute acids results in kinetically favored cleavage of peptide bonds 
at asparagine but with time others as well, while CNBr cleaves at less abundant 
methionine [31]. NTCB is specific towards cysteine, while hydroxyl amine reagent 
cleaves peptide bonds at asparagine and glycine. Generally, chemical mediated 
cleavage targets peptide bonds of less common amino acids producing long peptides 
useful in middle-down proteomics [30].
4. Technologies for analysis of limited sample amounts
Given that there is no technology to amplify proteins as may be done for nucleic 
acids with polymerase chain reaction, historically proteomics has faced limita-
tions in terms of the amount of starting material required for success. Traditional 
proteomics approaches to sample preparation such as filter-aided sample prepara-
tion (FASP), in-gel digestion, and in-solution digestion typically require at least 
several micrograms of a protein sample, which can be complicated to retrieve from 
representative clinical samples that are by default limited in availability. Therefore, 
the traditional method of defining proteomes has generally produced knowledge on 
the underlying biology that reflect averages rendered from analysis of mixtures of 
cells of different types present in tissue.
As proteomics and the requisite mass spectrometry instrumentation have 
evolved, microscale proteomic pipelines that decrease the amount of protein 
required to sub-microgram levels have become available. Microscale proteomics 
pipelines rely on modifications of traditional proteomics pipelines frequently 
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accompanied with cell sorting, laser capture tissue microdissection (LCM) or single 
cell extraction methods. Microdevices such as nano-capillary columns, microfluidic 
chips, miniaturised ESI introduction interfaces and miniaturised enzyme reac-
tors are often required [32]. Introducing microscale proteomics provides a clearer 
picture of reality as it substantially increases sensitivity, spatial proteome resolution 
and leads to better understanding of how protein networks coincide on microscopic 
level. Despite obvious benefits, microscale proteomics still requires special instru-
mentation making implementation of these protocols for the moment some what 
difficult across laboratories worldwide.
One recent promising such technology is nanoPOTS (nanodroplet processing 
in one pot for trace samples) (Figure 3A). The nanoPOTS platform is intended for 
processing small cell populations in nanoliter volumes. NanoPOTS benefits from 
downscaling the processing volumes that in turn substantially reduces surface asso-
ciated sample losses. The final step of nanoPOTS is accompanied with solid phase 
extraction (SPE) that concentrates, desalts and efficiently introduces a sample to 
nanoLC fluidics. Recently, a modification of nanoPOTS termed microPOTS was 
reported that is a more adoptable variant not requiring a robotic platform [33]. It 
has been reported that nanoPOTS could identify >3000 proteins from 10 cultured 
mammalian cells, while microPOTS has been reported to reproducibly identify up 
to 1200 and 1800 proteins from 25 HeLa cells and 50 mm square mouse liver tissue, 
respectively [33]. Several nanoPOTS modifications have been reported since it was 
Figure 3. 
Modern limited proteomic sample preparation approaches. (A) NanoPOTS; A limited proteomic sample 
preparation protocol that uses an automated robotic platform operating with nanoliter volumes. Sample is 
processed in a nano-well patterned slide. Sample preparation is based on principles of classical in-solution 
protein digestion. Protein digest is then transferred into SPE cartridge, where peptides are desalted and 
concentrated. Following, peptides are separated and analysed using mass spectrometry. (B) SCoPE-MS; a single 
cell proteome analysis platform. Carrier proteome is used to overcome sample losses accompanied due to peptide 
adsorption to surfaces. TMT labelling identifies the carrier and analysed proteomes. It could also serve for 
relative quantification of compared proteomes (SCoPE-MS2). Protein presence in the investigated sample and 
its quantity is determined based on reporter ion intensity.
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introduced. For example, Zhu et al. claim that a combination of nanoPOTS with 
fluorescence activated cell sorting (FACS) could detect 670 protein groups from a 
single mammalian cell [34]. Later a combination of nanoPOTS, nanoLC separation 
operated at 20 nL/min and Orbitrap Eclipse and Tribrid mass spectrometer led even 
to a slight increase in sensitivity identifying ~1000 protein groups from a single 
HeLa cell [35]. Extraordinary low sample requirements predispose nanoPOTS to 
being useful for LC–MS/MS tissue imaging. Spatially resolved proteomic maps of a 
mouse blastocyst embedding into placenta have been produced using a combination 
of nanoPOTS and LCM. The nanoPOTS - LCM combination produced quantitative 
tissue images for >2000 proteins with 100-μm spatial resolution which substantially 
outperformed classical protein imaging mass spectrometry (IMS) [36]. The univer-
sality of nanoPOTS is well documented in several publications summarising results 
from pancreas, liver brain tissue thin sections as well as plant samples.
Achieving submicrogram detection limits has also been reached by introducing a 
carrier proteome to decrease adsorption of the proteome of interest in combination 
with TMT labelling (Figure 3B). The carrier proteome spike-in helped the method 
known as Single-Cell-ProtEomics-by-Mass-Spectrometry (SCoPE MS) to over-
come extensive losses due to adsorption of proteins to surfaces (e.g. LC columns) 
while the addition of TMT labelling identifies the carrier and analysed proteomes. 
Moreover, TMT labels enable relative protein quantitation of multiple samples/
conditions per one LC–MS run. The SCoPE MS approach has enabled detection 
of >1000 proteins from a single mouse embryonic stem cell [37]. Specht et al. 
further exploited quantitative potential of TMT labels and claimed to reproducibly 
quantitate >1000 proteins in a SCoPE MS experiment investigating differentiating 
monocytes heterogeneity [38].
Introducing on-column immobilised protease digestion (IMER) downscales 
sample requirements up to the sub-microgram level, especially when combined 
with miniaturised column diameter. Utilising various nanostructured materials 
such as nanoporous material, nanoparticles, nanofibers and nanotubes succeeded in 
IMER nanobiocatalysis as it has led to enzyme stabilisation and increasing apparent 
enzyme activity per unit mass of immobilisation host [39]. Several sub-microgram 
proteomic setups combining IMER with downstream microfluidic platforms have 
been reported [40–42].
The microfluidic platform termed Open tubular lab-on-column combines 
LysC and trypsin enzymatic digestion on 20 mm inner diameter (ID) column with 
on-line connected nano LC–MS/MS system. Open tubular lab-on-column benefits 
from very narrow capillary ID and IMER column ID that prevent excessive peptide 
dilution and adsorption to fluidics. The authors detected a biomarker Axin 1 in 
10 ng of HCT15 colon cancer cells [40]. Huang et al. characterised 348 proteins 
from 25 mice blastocysts on a platform termed SNaPP coupling enzymatic digestion 
on 150 mm ID IMER to nanofluidics [41]. Naldi et al. coupled SCX column-based 
IMER proteomic reactor to nano-proteomic platform capable of protein capture, 
reduction, alkylation, digestion and the first dimensional SCX peptide pre-separa-
tion followed by LC–MS/MS. These authors claim that the platform performs with 
as low as 200 ng protein starting material [42]. Moreover, the integrated Proteome 
Analysis Device (iPAD) couples a 10 port valve, digestion loop and SPE trap column 
in a microfluidic setup that is intended for micro sample preparation prior to mass 
spectrometry. The authors claim that the iPAD approach is capable of identifying 
813 proteins in approx. 100 Duke’s type C colorectal adenocarcinoma [43].
Capillary electrophoresis (CE) is an efficient and sensitive separation tech-
nique reliably resolving proteins or peptides. Historically, it has been less robust 
than nanoLC but recently this has begun to change. Specifically, the introduction 
of CE-ESI interfaces that do not lead to an excessive peptide dilution have made 
11
Trends in Sample Preparation for Proteome Analysis
DOI: http://dx.doi.org/10.5772/intechopen.95962
CE-MS applicable in microproteomics [44]. Several reports describe various pro-
teomic pipelines coupling CE to MS. An ultrasensitive electrokinetically pumped 
nanospray ionization source coupled with CE was able to identify 283 proteins from 
80 ng of MCF7 breast cancer cells. Moreover, the detection limit of spiked-in angio-
tensin II in bovine serum albumin digest was 2 attomole/injection [45]. Although 
animal proteomics does not fall within scope of this chapter it is worth mentioning 
that CE-MS input allowed analysis down to 50 ng of Xenopus laevis eggs in a single 
protein extract. The authors of this study used linear polyacrylamide coating and 
sulfonate-silica hybrid strong cation exchange monolith for SPE followed by CE-MS 
[46]. Combining SPE with CE in 2D manner is a promising candidate for the future 
development of microscale CE-MS proteomics.
5. Conclusions and future perspectives
Developments in proteomics to identify clinically relevant proteins has been 
widely used in scientific research. Sample preparation has been considered as one of 
the key steps during analysis, and as such a variety of protocols to minimize vari-
ability and to obtain best sensitivity and protein recovery from the material have 
been used.
Constant development of technologies that could be applied in a medical 
context and potentially used for screening of patient samples have been rising in 
recent years. Technological evolution has also had an impact to provide platforms 
for proteome screening of limited cell numbers, i.e. some technologies have clearly 
demonstrated success on the single cell level. Cellular heterogeneity at the cellular 
level results during tumour development that can confound analysis. Therefore, 
advancement of the tools for profiling of cellular subpopulations or regions of 
tumours has great potential to provide novel insight in mechanisms of tumour 
growth. Moreover, integration of developed tools with machine learning algorithms 
to discover and map molecules that manifest pathological development will likely 
lead to a better understanding of mechanisms of oncogenesis and potentially 
uncover therapeutic targets.
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